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ABSTRACT 
Salicylaldehyde nicotinoyl hydrazone ( SANH ) has been synthesized.  Complexes of Salicylaldehyde nicotinoyl hydrazone with transition metals, Fe (II) &  
Cu (II) have been synthesized in ethanol medium. The formation of the complexes are endothermic processes. The ligand was characterized by melting point, 
elemental analysis, absorption spectra, NMR - 1 H prediction and antimicrobial activity while the complexes were characterized by melting point,absorption 
spectra. A simple & sensitive spectrophotometric method was developed for transition metal complexes of SANH. The optimum condition for complete colour 
development have been established. The stability constant, dissociation constant & change in free energy of Fe (II) & Cu (II) complexes with SANH are 
determined. Composition of the metal & ligand has been determined by Job’s variation & mole ratio method indicate that the M:L is 2:1. Tolerance limit of 
diverse ions in the determination of  Fe (II) & Cu (II) with Salicylaldehyde nicotinoyl hydrazone are investigated. 
Keywords: Salicylaldehyde nicotinoyl hydrazone, Fe (II), Cu (II), Spectrophotometry,Antimicrobial activity. 
 
INTRODUCTION 
Hydrazones are present in many of the bioactive heterocyclic 
compounds that are of wide interest because of their diverse 
biological  and  clinical  applications.  researchers  who  have 
The variety of hydrazide derivatives play various biological 
activities  viz.  anticancer,  anti-HIV
1,  anthelmintic
2, 
antimycobacterial
3,  anti-inflammatory
4,5,  antidiabetic
6, 
antimicrobial
7,8,9  ,  trypanocidal
10  analgesic
11-12  anti-
tuberculosis 
12-17  antimalarial  activities
18-20    antiparasitic 
activity
21    Hydrazone-based  coupling  methods  are  used  in 
medical biotechnology to couple drugs to targeted antibodies 
e.g.  antibodies  against  a  certain  type  of  cancer  cell.  The 
hydrazone-based bond is stable at neutral pH (in the blood), 
but  is  rapidly  destroyed  in  the  acidic  environment  of 
lysosomes of the cell.  
Iron  is  essential  for  cellular  growth  and  division,  as  Fe-
containing  proteins  catalyze  key  reactionsinvolving  energy 
metabolism, respiration, and DNA synthesis. In fact, without 
Fe, cells are unable to proceed from the G, to the S phase of 
the cell cycle
22 . Therefore, all cells require Fe and neoplastic 
cells have a high Fe requirementrelated to their rapid rate of 
replication 
23-24  Several studies have suggested that limiting 
Fe  uptake  by  tumor  cells  may  be  one  strategy  to  prevent 
cellular    Proliferation
25-27  .  A  number  of  reports  with  the 
Fe(II1) chelator, desferrioxamine (DFO),have shown that this 
ligand has a potent cytotoxic effect in vitro and in vivo on the 
common childhood cancer, neuroblastoma
28-32 In addition to 
its effects on NB cells, DFO has also been shown to have a 
favorable  antitumor  effect  on  human  melanoma  cells  in 
culture
32 .on human melanoma cells in culture
33 , on human 
hepatoma xenografts  in nude mice
34   and  in hematopoietic 
tumour
35 when DFO was used in combination with cytotoxic 
agents  in  a  patient  suffering  from  refractory  leukemia,  a 
partial  response  was  obtained
36    a  number  of  other  Fe 
chelators have also been examined for their antitumor effects, 
including  parabactim  a-ketohydroxypyridones
  37    and 
pyridoxal isonicotinoyl hydrazone (PIH) 
38  In addition to the 
antineoplastic effect of apochelators, ligand-metal complexes 
with both nonphysiologic metals platinum physiologic metals  
copper an also exhibit potent cytotoxicity
39 . 
Copper  is  known to  be  an  essential  element  in  the human 
body.  Copper  complexes  have  shown  to  have  a  beneficial 
effect in the treatment of inflammatory diseases. Copper has 
been  used  to  successfully  treat  patients  with  arthritic  and 
other  chronic  degenerative  diseases.  Anti-inflammatory 
agents (aspirin and ibuprofen, for example) have been shown 
to  be  more  active  than  their  parent  compounds.  Copper 
aspirinate has been shown not only to be more effective in the 
treatment of rheumatoid arthritis than aspirin alone, but it has 
been  shown  to  prevent  or  even  cure  the  ulceration  of  the 
stomach often associated with aspirin therapy. 
As early as 1912, patients were treated for skin cancer with a 
mixture  of  copper  chloride  and  lecithin.  Success  of  such 
treatment suggested that copper compounds have anticancer 
activity. In 1930, work in France indicated that injections of 
colloidal copper expelled tumor tissue.  Copper has a direct 
effect  on  the  control  of  cholesterol.  It  is  believed  that  a 
metabolic  imbalance  between  zinc  and  copper  is  a  major 
cause of coronary heart disease. Copper complexes can also 
have a valuable role in the minimizing damage to the heart 
muscle following a heart attack. This action is based on the 
anti-inflammatory  action  of  copper.copper  will  become  an 
increasingly  important  component  of  tomorrow's  medical 
treatments. Copper also displays potent anti-viral activity
39 . 
Introducing  copper  into  cotton  fibers,  latex  and  other 
polymeric  materials  enables  the  production  of  clothing, 
bedding and medical devices that possess biocidal properties 
40 .Some examples include anti-viral gloves and filters (which 
deactivate  HIV-1  and  other  viruses),  anti-bacterial  self-
sterilizing  fabrics  (which  kill  antibiotic  resistant  bacteria), 
anti-fungal  socks  (which  alleviate  symptoms  of  athlete’s 
foot), and anti-dust mite mattress-covers (which reduce mite-
related allergies)
41 . Today copper is used as a water purifier, 
algaecide,  fungicide,  nematocide,  molluscicide,  and  as  an 
anti-bacterial and anti-fouling agent 
42-46  .It is considered safe 
to humans, as demonstrated by the widespread and prolonged 
use of copper intrauterine devices by women
47-48 .  
MATERIALS AND METHODS 
Melting points were determined by open capillaries method. 
All chemical and solvents used were of analytical grade .An Borhade Shobha: Transition metal complexes of SANH antibacterial activity 
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Elico pH meter LI-610 is used for the pH  measurements. An 
Elico  UV-visible  spectrophotometer  model  UV-SL-164 
equipped with 1 cm quartz cell used for spectrophotometeric 
measurements. Elemental analysis and antimicrobial activity 
was done in Laboratory approved by Central Government for 
AGMARK.   
 
SYNTHESIS AND CHARACTERISATION  OF  SALICYLALDEHYDE NICOTINOYL  HYDRAZONE  (SANH) 
Synthesis of  Salicylaldehyde nicotinoyl hydrazone 
 
N ic o tin ic  a c id  h y d r a z id e
N
O
N H
H 2 N
S a lic y la ld e h y d e
H O
O
S a lic y la ld e h y d e  n ic o tin o y l h y d r a z o n e
O H N
N H
N
O
 
( E ) –N’-(2-Hydroxbenzylidene)nicotinohydrazide 
 
The  crude  product  was  crystallized  in  methanol.  The 
recrystallized  product  has  melting  point  is  160
0C  and 
molecular weight by formula is 238.00. 
Characterization of  Salicylaldehyde nicotinoyl hydrazone 
(SANH) 
Absorption Spectra of SANH 
Absorption Spectra of  SANH was recorded against a blank 
solution containing buffer 
 (  pH  2  )  .  Absorption  spectra  was  recorded  in  the  wave 
length range 250 nm-430 nm. SANH shows an absorption 
maximum  at  300  nm.  At  300  nm  wavelength  the  molar 
absorptivity of  SANH is  0.991 x 10
3 L.mol
-1.cm
-1. Fig 1. 
Elemental Analysis of  SANH 
The elemental analysis  of  SANH was done in Laboratory 
approved  by  Central  Government  for  AGMARK.  It  shows 
the result of elemental analysis in Table 1. 
Antimicrobial Activity of SANH 
Antimicrobial  Activity  of    SANH    has  been  done  in  the 
Laboratory approved by Central Government  for AGMARK. 
The result are noted in Table 2. 
NMR H-1 Prediction 
NMR H-1 Prediction of SANH is  shown in Table 6  & Fig 2. 
Characterisation  of  SANH  Complex  with  Transition 
Metal 
Absorption Spectra of  Fe (II)-SANH & Cu (II)-SANH was 
recorded against a blank solution containing buffer ( pH 2). 
Absorption  spectra  was recorded  in the  wave  length range 
250  nm-430  nm.  The  complex  shows  an  absorption 
maximum at 335 nm & 315 nm.  Fig 1. 
Effect of Reagent concentration 
Effect  of  Reagent  concentration  was  studied  by  taking 
varying  amount  of  reagent  and  fixed  amount  of  transition 
metal. 
Validity of Beer’s Law and Composition of Complex  
For  the  study  of  Beer’s  law  the  solutions  were  prepared 
which containing different amounts of 
Fe (II), & Cu (II) ,  same amount of SANH & 1 ml of buffer  
pH 2 .The composition of the Fe (II)-SANH & Cu (II)-SANH 
complex is found to be 1:2 . It was determined by studying 
Job’s method. The ratio of metal ion to ligand molecule in the 
coloured complex was found to be 1:2 
Experimental result and physical data of  SANH complexes 
with Fe (II ) & Cu(II) shown in Table 4 
Physico-chemical Characteristic of  Fe (II)-SANH & Cu 
(II)-SANH Complex 
Physico-chemical  and Analytical characteristic of  transition 
metal complex of SANH was studied and given in Table 4 . 
Tolerance limit of diverse ions  of transition metal complexes 
of SANH in Table 5. 
 
Table No. 1.Elemental Analysis of  Salicylaldehyde nicotinoyl hydrazone 
Sr No.  Chemical 
Analysis 
Percentage 
Found 
Percentage 
Expected 
1)  Carbon  61.32 %  65.55 % 
2)  Hydrogen  05.97 %  06.30 % 
3)  Oxygen  06.01 %  06.72 % 
4)  Nitrogen  19.87 %  21.43 % 
 
Table No. 2. Antimicrobial  Activity  of  Salicylaldehyde nicotinoyl 
hydrazone 
Sr.No.  Antimicrobial  Activity 
 
1)  Klebsiella  Pneumoniae  Nil 
2)  Vibriae  Cholerease  Nil 
3)  Bacillus  Megaterium  Nil 
4)  Salmonalla  typhi  Nil 
5)  Shigella  Flexneri  Nil 
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Table No.3. Experimental Result & Physical data of Salicylaldehyde nicotinoyl  hydrazone  & its Complexes 
Code  No  Compound 
M.P. ( 
0C ) 
Colour  Molecular Weight by Formula  
gm/mole 
Yield 
SANH  160
0C  Yellow  238  89 % 
Fe (II)-SANH  137
0C  Greenish Yellow  293.845  76 % 
Cu (II)-SANH  129
0C  Bluish Yellow  301.546  71 % 
 
Table No.4. Physico-Chemical and Analytical Characteristic  of  Transition Metal Complex of Salicylaldehyde nicotinoyl hydrazone 
Sr.No.  Characteristics  Result 
    Fe (II)-SANH  Cu (II)-SANH 
 
1)  Absorption  Spectra  335 nm  315 nm 
2)  Molar  absorptivity  0.9750 x 10
 3 Lit. mol
-1. 
cm
-1 
0.5243 x 10
 3 Lit. mol
-1. cm
-
1 
3)  pH  range  ( optimum )  3.0  4.0 
4)  Reagent  required  for maximum  complexation  0.127 ml  0.200ml 
5)  pKa  6.004 x 10
 8  4.9014 x 10
 8 
6)  Beer’s  law   validity   range ( ppm)  9 ppm  8.5 ppm 
7)  Composition  of  complex  ( M : L )  1:2  1:2 
8)  Stability  Constant  3.85041 x 10
 7  4.05903 x 10
 7 
9)  Dissociation  Constant  3.00416 x 10 
– 8  2.96630 x 10 
– 8 
10)  Change  in free  energy  -40.37 KJ/mole  -52.535KJ/mole 
11)  Sandell’s  Sensitivity  ( µg /cm
 2 )  0.003221 µg /cm
 2  0.005111 µg /cm
2 
 
Table No.5. Tolerance limit of diverse ions of Transition Metal Complex of SANH 
Sr. No.  Metal ion  Salt  Interference 
 
      Fe (II)-SANH  Cu (II)-SANH 
1)  Mg (II )  MgSO4  140  100 
2)  Ca(II )  CaCl2.2H2O  86  69 
3)  Cd (II )  CdCl2  10  08 
4)  Mn (II )  MnCl2  50  24 
5)  Co ( II )  CoSO4  Interferes  04 
6)  Ce ( IV )  Ce (SO4 )2  10  35 
7)  Ba ( II )  BaCl2  24  Interfere 
8)  Cr ( III )  K2Cr2O7  25  13 
9)  Hg ( II )  HgCl2  08  Interfere 
10)  Ti (V )  K-titanyl  oxalate  19  97 
11)  Ni ( II )  NiCl2  54  Interfere 
12)  Sn ( II )  SnCl2  73  19 
13)  Na (I)  NaCl  37  50 
14)  Pb (II )  PbSO4  70  68 
15)  V ( v)  V2O5  Interferes  Interfere 
16)  Zn ( II )  ZnSO4  33  24 
17)  Al ( III )  AlCl3  Interferes  32 
18)  Pd ( II )  PdCl2  Interferes  69 
19)  K( II)  KCl  04  Interfere 
 
Table  No .6.NMR H-1 Prediction 
Sr.No.  Types of Proton  Node  Chemical Shift ( PPM ) 
1)  Benzylidenimin  CH  8.11 
2)  Aromatic C-OH  OH  5.00 
3)  Secondary amide  NH  8.00 
4)  3-Pyridine  CH  7.75 
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Fig No.1.Absorption Spectra of  Salicylaldehyde nicotinoyl hydrazone  & Complexes 
 
 
 
 
a-------Absorption spectra SANH 
b-------Absorption spectra Fe (II)- SANH 
c------- Absorption spectra Cu (II)- SANH 
 
Fig No .2 . NMR H-1 Prediction of  Salicylaldehyde nicotinoyl hydrazone 
 
0 1 2 3 4 5 6 7 8 9
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RESULT AND DISCUSSION 
Salicylaldehyde nicotinoyl hydrazone  and its complexes with 
Fe (II) and Cu (II) was synthesized. Colour of SANH, Fe(II)-
SANH & Cu (II) –SANH was yellow, greenish yellow and 
bluish  yellow.  Their  molecular  weight  by  formula  is  238 
gm/mole, 293.845 gm/mole & 301.546 gm/mole. The yield 
of different synthesized compounds were found to be range 
of 70 -90 % and characterization was done by melting point. 
SANH  shows an absorption maxima at 300 nm, Absorption 
maxima of Fe (II)-SANH at 335 nm & for Cu (II) –SANH  at 
315  nm.  Elemental  analysis  of  SANH  shows  that  carbon 
61.32 %, hydrogen 05.97 %, oxygen 06.01 % and nitrogen 
19.87 %.  Salicylaldehyde nicotinoyl hydrazone  known for 
their good antimicrobial properties. Antimicrobial activities 
were  carried  out    by    Klebsiella    Pneumoniae  ,  Vibriae  
Cholerease  ,  Bacillus    Megaterium  ,  Salmonalla    typhi  & 
Shigella    Flexneri.  Composition  of  the  complexes  
1:2.Stability constant, Dissociation constant, Change in free 
energy  of  Fe  (II)-SANH    complex  was    3.85041  x  10
  7,  
3.00416 x 10 
–  8,  - 40.37 KJ/mole & for Cu (II) –SANH 
complex  was  4.05903  x  10
  7  ,  2.96630  x  10 
–  8  ,  - 
52.535KJ/mole respectively. 
CONCLUSION 
The  objective  of  the  present  work  was  to  synthesized 
Salicylaldehyde  nicotinoyl  hydrazone  Fe  (II)- 
Salicylaldehyde  nicotinoyl  hydrazone    &  Cu  (II)- 
Salicylaldehyde nicotinoyl hydrazone purity, characterize and 
evaluate  the antimicrobial  activity.  Fe(II)-SANH  &  Cu(II)-
SANH shows 1:2 complexation. 
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